Similarly, the mRNA expression of brain natriuretic peptide and β-myosin heavy chain as markers of cardiac hypertrophy was dose-dependently reduced by Ang-(1–7) treatment, which was also enhanced by co-administration of perindopril and completely reversed by PD123319 (Fig. 3E and F). This evidence concerns the gene NPPB and cardiac hypertrophy.